Symbol,Name,HGNC_ID,Evidence,Test method,Test in,Test setting,Pathway,Confidence,Caution,Protein encoded,UniProtKB,PMID,Remark
SLC7A11,Solute carrier family 7 member 11,HGNC:11059,"Silencing of SLC7A11 sensitized HT-1080 cells to erastin-induced death, whereas transfection of HT-1080 cells with a plasmid encoding SLC7A11 conferred protection from erastin- and sulfasalazine-induced death.","RT-qPCR, siRNA, gene transfection, cell viability",Human,HT-1080 cells,"SLC7A11 :+: Cystine, Cystine :-: Ferroptosis",Validated,_NA_,Cystine/glutamate transporter,Q9UPY5 (XCT_HUMAN),22632970,_NA_
GPX4,Glutathione peroxidase 4,HGNC:4556,RNAi-mediated GPX4 knockdown induces ferroptosis.,"Affinity-based chemoproteomics, western blotting, and RNAi","Human, mice","HRAS mutant BJeLR-engineered tumor cells, HT-1080 cells, xenograft mouse model (athymic nude mice injected with four million HT-1080 cells)","GPX4 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Phospholipid hydroperoxide glutathione peroxidase,P36969 (GPX4_HUMAN),24439385,_NA_
AKR1C1,Aldo-keto reductase family 1 member C1,HGNC:384,Up-regulated in DU-145 erastin-resistant clones. Participate in the detoxification of toxic lipid metabolites. May confer partial resistance to erastin by enhancing the detoxification of reactive aldehydes generated downstream of the oxidative destruction of the plasma membrane during ferroptosis.,"RNA-seq, glutamate release assay, cell growth, flow cytometry",Human,DU-145 prostate cancer cells,AKR1C1 :-: Ferroptosis,Validated,_NA_,Aldo-keto reductase family 1 member C1,Q04828 (AK1C1_HUMAN),24844246,_NA_
AKR1C2,Aldo-keto reductase family 1 member C2,HGNC:385,Up-regulated in DU-145 erastin-resistant clones. Participate in the detoxification of toxic lipid metabolites. May confer partial resistance to erastin by enhancing the detoxification of reactive aldehydes generated downstream of the oxidative destruction of the plasma membrane during ferroptosis.,"RNA-seq, glutamate release assay, cell growth, flow cytometry",Human,DU-145 prostate cancer cells,AKR1C2 :-: Ferroptosis,Validated,_NA_,Aldo-keto reductase family 1 member C2,P52895 (AK1C2_HUMAN),24844246,_NA_
AKR1C3,Aldo-keto reductase family 1 member C3,HGNC:386,Up-regulated in DU-145 erastin-resistant clones. Participate in the detoxification of toxic lipid metabolites. May confer partial resistance to erastin by enhancing the detoxification of reactive aldehydes generated downstream of the oxidative destruction of the plasma membrane during ferroptosis.,"RNA-seq, glutamate release assay, cell growth, flow cytometry",Human,DU-145 prostate cancer cells,AKR1C3 :-: Ferroptosis,Validated,_NA_,Aldo-keto reductase family 1 member C3,P42330 (AK1C3_HUMAN),24844246,_NA_
GPX4,Glutathione peroxidase 4,HGNC:4556,Knockout of glutathione peroxidase 4 (Gpx4) causes cell death in a pathologically relevant form of ferroptosis. Knockdown renders cells more sensitive to ferroptosis-inducing agents.,"Cell viability assessment, siRNA","Human, mice","Mouse embryonic fibroblast (MEF) cells (Pfa1 cells), Gpx4−/− cells and mice, HK-2 cells","GPX4 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Phospholipid hydroperoxide glutathione peroxidase,P36969 (GPX4_HUMAN),25402683,_NA_
RB1,RB transcriptional corepressor 1,HGNC:9884,Rb knock-down cells exposed to sorafenib encounter ferroptosis. Lack of Rb sensitized HCC cells to the induction of ferroptosis.,"RNA interference, cell viability assay, oxidative stress measurement","Human, mice",HCC cell lines Huh7 and PLC/PRF5; Balb/c nude mice received tumour xenografts derived from HCC cells.,RB1 :-: Ferroptosis,Validated,_NA_,Retinoblastoma-associated protein,P06400 (RB_HUMAN),25444922,_NA_
HSPB1,Heat shock protein family B (small) member 1,HGNC:5246,"Knockdown of HSF1 and HSPB1 enhances erastin-induced ferroptosis, whereas heat shock pretreatment and overexpression of HSPB1 inhibits erastin-induced ferroptosis.","RNAi, RT-qPCR, western blot, cell viability","Human, mice","HeLa and U2OS cells, human xenograft mouse tumor derived from HeLa (#CCL-2) cells.",HSPB1 :-: Ferroptosis,Validated,_NA_,Heat shock protein beta-1,P04792 (HSPB1_HUMAN),25728673,_NA_
HSF1,Heat shock transcription factor 1,HGNC:5224,"Knockdown of HSF1 and HSPB1 enhances erastin-induced ferroptosis, whereas heat shock pretreatment and overexpression of HSPB1 inhibits erastin-induced ferroptosis.","RNAi, RT-qPCR, western blot, cell viability","Human, mice","HeLa and U2OS cells, human xenograft mouse tumor derived from HeLa (#CCL-2) cells.",HSF1 :-: Ferroptosis,Validated,_NA_,Heat shock factor protein 1,Q00613 (HSF1_HUMAN),25728673,_NA_
SLC7A11,Solute carrier family 7 member 11,HGNC:11059,Overexpressed in human cancer specimens. Overexpression inhibits ROS-induced ferroptosis.,"Western blot, cell death test, ChIP assay, RT-PCR, immunofluorescence staining, colony formation assay, TUNEL and BrdU assay","Human, mice","H1299 cells, mouse embryonic fibroblasts, transgenic mice; colon, liver and kidney tumour samples; mouse xenograft","SLC7A11 :+: Cystine, Cystine :-: Ferroptosis",Validated,_NA_,Cystine/glutamate transporter,Q9UPY5 (XCT_HUMAN),25799988,_NA_
GPX4,Glutathione peroxidase 4,HGNC:4556,"Ex vivo, Gpx4-deficient T cells rapidly accumulated membrane lipid peroxides and concomitantly underwent cell death driven by ferroptosis.","Viability assays, flow cytometry, lipid peroxidation assay",Mice,T cells,GPX4 :-: Ferroptosis,Validated,_NA_,Phospholipid hydroperoxide glutathione peroxidase,P36969 (GPX4_HUMAN),25824823,_NA_
GCLC,Glutamate-cysteine ligase catalytic subunit,HGNC:4311,RNAi knockdown sensitized cell death induced by cystine starvation.,"RNAi, qPCR",Mice,Mouse embryonic fibroblasts,"GCLC :+: GSH, GSH :-: Ferroptosis",Validated,_NA_,Glutamate--cysteine ligase catalytic subunit,P48506 (GSH1_HUMAN),26166707,_NA_
SLC7A11,Solute carrier family 7 member 11,HGNC:11059,Overexpression of SLC7A11 considerably abrogated ferroptosis.,"Cell death quantification, gene transfection, western blot",Human,H1299 cells,SLC7A11 :-: Ferroptosis,Validated,_NA_,Cystine/glutamate transporter,Q9UPY5 (XCT_HUMAN),26218928,_NA_
NFE2L2,"Nuclear factor, erythroid 2 like 2",HGNC:7782,NRF2 plays a central role in protecting hepatocellular carcinoma (HCC) cells against ferroptosis,"Cell Viability Analysis, western blot, RNAi, qRT-PCR","Human, mice","HepG2, Hepa1‐6, Hep3B, and SNU‐182 cells, C57BL/6 mice","NFE2L2 :+: (NQO1/HMOX1/FTH1), (NQO1/HMOX1/FTH1) :-: Ferroptosis",Validated,_NA_,Nuclear factor erythroid 2-related factor 2,Q16236 (NF2L2_HUMAN),26403645,NRF2 in article
SQSTM1,Sequestosome 1,HGNC:11280,"The interaction between p62 and Keap1 increased following erastin and sorafenib treatment. Knockdown of p62 suppressed NRF2 expression and promoted growth inhibition with increased ferroptotic events including GSH depletion, lipid ROS production, and an increase of iron levels.","Immunoprecipitation assay, shRNA knockdown, iron assay, lipid peroxidation assay, glutathione assay, cell viability","Human, mice","HepG2, Hepa1‐6, Hep3B, and SNU‐182 cells","SQSTM1 :-: KEAP1, KEAP1 :-: NFE2L2, NFE2L2 :-: Ferroptosis",Validated,_NA_,Sequestosome-1,Q13501 (SQSTM_HUMAN),26403645,p62 in article.
NQO1,NAD(P)H quinone dehydrogenase 1,HGNC:2874,"Knockdown of p62, quinone oxidoreductase‐1, heme oxygenase‐1, and ferritin heavy chain‐1 by RNA interference in HCC cells promoted ferroptosis in response to erastin and sorafenib.","qRT‐PCR, RNA interference","Human, mice","HepG2, Hepa1‐6, Hep3B, and SNU‐182 cells",NQO1 :-: Ferroptosis,Validated,_NA_,NAD(P)H dehydrogenase [quinone] 1,P15559 (NQO1_HUMAN),26403645,_NA_
HMOX1,Heme oxygenase 1,HGNC:5013,"Knockdown of p62, quinone oxidoreductase‐1, heme oxygenase‐1, and ferritin heavy chain‐1 by RNA interference in HCC cells promoted ferroptosis in response to erastin and sorafenib.","qRT‐PCR, RNA interference","Human, mice","HepG2, Hepa1‐6, Hep3B, and SNU‐182 cells",HMOX1 :-: Ferroptosis,Validated,Article (PMID 26405158) suggests it a driver.,Heme oxygenase 1,P09601 (HMOX1_HUMAN),26403645,HO1 in article
FTH1,Ferritin heavy chain 1,HGNC:3976,"Knockdown of p62, quinone oxidoreductase‐1, heme oxygenase‐1, and ferritin heavy chain‐1 by RNA interference in HCC cells promoted ferroptosis in response to erastin and sorafenib.","qRT‐PCR, RNA interference","Human, mice","HepG2, Hepa1‐6, Hep3B, and SNU‐182 cells",FTH1 :-: Ferroptosis,Validated,_NA_,Ferritin heavy chain,P02794 (FRIH_HUMAN),26403645,_NA_
MUC1,"Mucin 1, cell surface associated",HGNC:7508,MUC1-C (C-terminal subunit) blocks erastin-induced ferroptosis and induces increases in GSH.,"shRNA, GSH level measurement, cell death test",Human,"MDA-MB-468, BT-20 cells","MUC1 :+: System Xc-, System Xc- :+: GSH, GSH :-: Ferroptosis",Validated,_NA_,Mucin-1,P15941 (MUC1_HUMAN),26930718,_NA_
SLC3A2,Solute carrier family 3 member 2,HGNC:11026,Required for in vitro cell survival because of its role in protecting cells from ferroptosis.,Cell survival test,Mice,Mouse ES-derived fibroblasts,"SLC3A2 :+: System Xc-, System Xc- :-: Ferroptosis",Validated,_NA_,4F2 cell-surface antigen heavy chain,P08195 (4F2_HUMAN),26945935,CD98hc in article
MT1G,Metallothionein 1G,HGNC:7399,"A negative regulator of ferroptosis in HCC cells. Knockdown of MT‐1G by RNA interference increases glutathione depletion and lipid peroxidation, which contributes to sorafenib‐induced ferroptosis.","RNA interference, cell viability assay, colony formation assay, western blot, qRT-PCR, glutathione assay, lipid peroxidation assay","Human, mice","HCC cells (HepaG2, Hep3B, and Huh7 cells), nude mice.",MT1G :-: Ferroptosis,Validated,_NA_,Metallothionein-1G,P13640 (MT1G_HUMAN),27015352,MT‐1G in article
NFE2L2,"Nuclear factor, erythroid 2 like 2",HGNC:7782,Required for sorafenib‐induced expression of MT‐1G which is a ferroptosis suppressor.,"shRNA, qRT-PCR, western blot",Human,Huh7 and/or HepG2 cells,"NFE2L2 :+: MT1G, MT1G :-: Ferroptosis",Deduced,"Its ability to induce MT1G was validated, but its role in ferroptosis needs validation.",Nuclear factor erythroid 2-related factor 2,Q16236 (NF2L2_HUMAN),27015352,NRF2 in article
SLC40A1,Solute carrier family 40 member 1,HGNC:10909,Involved in siramesine and lapatinib-induced ferroptotic cell death. Its expression is decreased after treatment with siramesine alone or in combination with lapatinib. Overexpression FPN resulted in decreased ROS and cell death whereas knockdown of FPN increased cell death after siramesine and lapatinib treatment.,"Western blot, densitometry quantification, siRNA, gene transfection, cell death test",Human,MDA MB 231 and SKBr3 cells,"SLC40A1 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Solute carrier family 40 member 1,Q9NP59 (S40A1_HUMAN),27441659,Ferroportin-1 (FPN) in article
SLC7A11,Solute carrier family 7 member 11,HGNC:11059,Knockdown increased cell death.,"siRNA, western blot, cell death test",Human,MDA MB 231 cells,"SLC7A11 :+: GSH, GSH :-: Ferroptosis",Validated,_NA_,Cystine/glutamate transporter,Q9UPY5 (XCT_HUMAN),27441659,_NA_
GPX4,Glutathione peroxidase 4,HGNC:4556,Knockdown increased cell death.,"siRNA, western blot, cell death test",Human,MDA MB 231 and SKBr3 cells,GPX4 :-: Ferroptosis,Validated,_NA_,Phospholipid hydroperoxide glutathione peroxidase,P36969 (GPX4_HUMAN),27441659,_NA_
SLC7A11,Solute carrier family 7 member 11,HGNC:11059,Inhibition induces ferroptosis. Silencing of the SLC7A11 gene increases the cisplatin sensitivity of resistant HNC cells.,"Cell viability, western blot, siRNA or shRNA, glutathione and ROS production measurements","Human, mice","AMC-HN3R, -HN4R, and -HN9R head and neck cancer cells, BALB/c male nude mice",SLC7A11 :-: Ferroptosis,Validated,_NA_,Cystine/glutamate transporter,Q9UPY5 (XCT_HUMAN),27477897,_NA_
CISD1,CDGSH iron sulfur domain 1,HGNC:30880,Genetic inhibition of CISD1 contributes to erastin-induced ferroptosis. Stabilization of the iron sulfur cluster of CISD1 inhibits ferroptosis.,"Cytotoxicity assays, western blot, q-PCR, RNAi",Human,HepG2 and Hep3B cells,"CISD1 :-: Mitochondrial lipid ROS, Mitochondrial lipid ROS :+: Ferroptosis",Validated,_NA_,CDGSH iron-sulfur domain-containing protein 1,Q9NZ45 (CISD1_HUMAN),27510639,_NA_
SLC7A11,Solute carrier family 7 member 11,HGNC:11059,Elevated levels of expression are resistant to erastin-induced ferroptosis. Repression of SLC7A11 expression by p53 sensitized cells to undergo erastin-induced ferroptosis.,"Western blot, cell death assay, qPCR",Human,H1299 cells,SLC7A11 :-: Ferroptosis,Validated,_NA_,Cystine/glutamate transporter,Q9UPY5 (XCT_HUMAN),27705786,_NA_
FANCD2,FA complementation group D2,HGNC:3585,Inhibits erastin-induced ferroptosis. Plays a novel role in the negative regulation of ferroptosis.,"Cell viability assay, Q-PCR, western blot, iron assay, lipid peroxidation assay, glutathione assay",Mice,Bone marrow stromal cells,FANCD2 :-: Ferroptosis,Validated,_NA_,Fanconi anemia group D2 protein,Q9BXW9 (FACD2_HUMAN),27773819,_NA_
GPX4,Glutathione peroxidase 4,HGNC:4556,Protects lipid peroxidation. Cell damage induced by GPx4 ablation is involved in ferroptosis.,"RT-PCR, western blot, cytotoxicity assay, cell proliferation assay, siRNA",Human,Umbilical vein endothelial cell,"GPX4 :-: LDH, LDH :+: Ferroptosis",Validated,_NA_,Phospholipid hydroperoxide glutathione peroxidase,P36969 (GPX4_HUMAN),27964880,_NA_
NFE2L2,"Nuclear factor, erythroid 2 like 2",HGNC:7782,Nrf2 activation contributes to the resistance of HNCs to artesunate-induced ferroptosis. Nrf2 inhibition sensitizes head and neck cancer cells to artesunate-induced ferroptosis.,"Cell viability assay, RNAi, gene transfection, western blot",Mice,"Head and neck cancer cells (HN2–10), nude mice",NFE2L2 :-: Ferroptosis,Validated,_NA_,Nuclear factor erythroid 2-related factor 2,Q16236 (NF2L2_HUMAN),28012440,NRF2 in article
FTMT,Ferritin mitochondrial,HGNC:17345,Overexpression significantly inhibited erastin-induced ferroptosis.,"Cell viability assay, western blot","Mice, fly","SH-SY5Y cells, drosophila melanogasters W1118, elav-Gal4 and UAS-Fer3HCH","FTMT :-: Labile iron pool, Labile iron pool :+: Ferroptosis",Validated,_NA_,Ferritin,Q8N4E7 (FTMT_HUMAN),28066232,_NA_
HSPA5,Heat shock protein family A (Hsp70) member 5,HGNC:5238,Negatively regulates ferroptosis. Suppression of HSPA5 expression increased erastin-induced death. Overexpressed HSPA5 inhibited erastin-induced ferroptotic cell death.,"Cell viability assay, western blot, shRNA, gene transfection","Human, mice","Pancreatic ductal adenocarcinoma cell lines (PANC1, CFPAC1, MiaPaCa2), nude mice, B6 mice","HSPA5 :+: GPX4, GPX4 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Endoplasmic reticulum chaperone BiP,P11021 (BIP_HUMAN),28130223,_NA_
ATF4,Activating transcription factor 4,HGNC:786,"Inhibition of ATF4 expression increased erastin-induced cell death. ATF4 results in the induction of HSPA5, which in turn protects against GPX4 protein degradation and subsequent ferroptosis.","CCK8 cell viability assay, clonogenic cell survival assay, western blot, q-PCR, RNAi",Human,"Pancreatic ductal adenocarcinoma cells (e.g., PANC1, CFPAC1, MiaPaCa2, and Panc2.03)","ATF4 :+: HSPA5, HSPA5 :+: GPX4, GPX4 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Cyclic AMP-dependent transcription factor ATF-4,P18848 (ATF4_HUMAN),28130223,_NA_
SLC7A11,Solute carrier family 7 member 11,HGNC:11059,Slc7a11 deletion increases susceptibility to iron overload-induced ferroptosis.,"Cell viability, RNAi, RT-PCR",Mice,"Mice, hepatocytes, bone marrow–derived macrophages",SLC7A11 :-: Ferroptosis,Validated,_NA_,Cystine/glutamate transporter,Q9UPY5 (XCT_HUMAN),28195347,_NA_
GPX4,Glutathione peroxidase 4,HGNC:4556,Ferroptosis drives neurodegeneration in Gpx4BIKO mice.,"RT-qPCR, behavior test, western blot",Mice,Forebrain neurons of Gpx4BIKO mice and Gpx4(f/f) mice,GPX4 :-: Ferroptosis,Validated,_NA_,Phospholipid hydroperoxide glutathione peroxidase,P36969 (GPX4_HUMAN),28212525,_NA_
GPX4,Glutathione peroxidase 4,HGNC:4556,Downregulation conferred increased sensitivity to ferroptosis following cystine deprivation.,"Immunoblotting, cell viability",Human,Human mammary epithelial cells,"GPX4 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Phospholipid hydroperoxide glutathione peroxidase,P36969 (GPX4_HUMAN),28297659,_NA_
HMOX1,Heme oxygenase 1,HGNC:5013,Demonsrates antiferroptotic role. HO-1 deficiency promotes erastin-induced ferroptosis.,"RT-PCR, western blot, cell viability, siRNA",Mice,Renal proximal tubule cells,HMOX1 :-: Ferroptosis,Validated,Article (PMID 26405158) suggests it a driver.,Heme oxygenase 1,P09601 (HMOX1_HUMAN),28515173,HO-1 in article
ATF4,Activating transcription factor 4,HGNC:786,ATF4 expression induces acquired cell death resistance. ATF4 knockdown renders cells susceptible for ferroptosis.,"siRNA, cell transfection, cell viability assay, RT-PCR, immunoblotting",Human,U87 and U251 glioblastoma cells,"ATF4 :+: xCT, xCT :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Cyclic AMP-dependent transcription factor ATF-4,P18848 (ATF4_HUMAN),28553953,_NA_
NFE2L2,"Nuclear factor, erythroid 2 like 2",HGNC:7782,Nrf2 over expression promotes resistance to ferroptosis.,Cell growth assay,"Human, rat","F98, U87 glioma cells","NFE2L2 :+: xCT, xCT :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Nuclear factor erythroid 2-related factor 2,Q16236 (NF2L2_HUMAN),28805788,Nrf2 in article
TP53,Tumor protein p53,HGNC:11998,Inhibits ferroptosis in human colorectal cancer (CRC) cells. Loss of TP53 restored erastin sensitivity. Inhibits cell death induction by erastin in human CRC cells.,"RNAi, live-cell imaging, cell viability, qPCR, western blot","Human, mice","HCT116, athymic nude mice","TP53 :+: Nucleus DPP4, Nucleus DPP4 :+: SLC7A11, SLC7A11 :-: Ferroptosis",Validated,Promotes ferroptosis via a transcription-dependent mechanism in non-CRC cells.,Cellular tumor antigen p53,P04637 (P53_HUMAN),28813679,_NA_
SLC7A11,Solute carrier family 7 member 11,HGNC:11059,Knockdown sensitized cells to erastin.,"shRNA, cell viability",Human,HCT116,SLC7A11 :-: Ferroptosis,Validated,_NA_,Cystine/glutamate transporter,Q9UPY5 (XCT_HUMAN),28813679,_NA_
HELLS,"Helicase, lymphoid specific",HGNC:4861,LSH inhibits ferroptosis by decreasing the intracellular levels of iron and lipid ROS.,"Plate-colony formation assay; measurement of total ROS, Lipid ROS, and intracellular iron","Human, mice","Lung cancer H358 and PC9 cells, SCID Mice","HELLS :+: GLUT1, HELLS :+: SCD, HELLS :+: FADS2, GLUT1 :-: Ferroptosis, SCD :-: Ferroptosis, FADS2 :-: Ferroptosis",Validated,_NA_,Lymphoid-specific helicase,Q9NRZ9 (HELLS_HUMAN),28900510,LSH in article
SCD,Stearoyl-CoA desaturase,HGNC:10571,Depletion of the SCD1 and FADS2 metabolic genes induces ferroptosis.,"shRNA, RT-qPCR, MTT assay, total iron detection, lipid ROS detection",Human,A549 cancer cells,SCD :-: Ferroptosis,Validated,_NA_,Acyl-CoA desaturase,O00767 (ACOD_HUMAN),28900510,SCD1 in article
FADS2,Fatty acid desaturase 2,HGNC:3575,Depletion of the SCD1 and FADS2 metabolic genes induces ferroptosis.,"shRNA, RT-qPCR, MTT assay, total iron detection, lipid ROS detection",Human,A549 cancer cells,FADS2 :-: Ferroptosis,Validated,_NA_,Acyl-CoA 6-desaturase,O95864 (FADS2_HUMAN),28900510,_NA_
SRC,"SRC proto-oncogene, non-receptor tyrosine kinase",HGNC:11283,"Src-STAT3 activation renders the cell unable to undergo to ferroptosis. Src inhibition decreased cell viability significantly, and that loss of viability was rescued by ferroptosis inhibitors.","Immunoblotting, RNAi, qPCR, western blot, cell viability",Human,MCF-10A and SUM-159 cells,"SRC :+: STAT3, STAT3 :-: ACSL4, ACSL4 :+: Ferroptosis",Validated,_NA_,Proto-oncogene tyrosine-protein kinase Src,P12931 (SRC_HUMAN),28972104,_NA_
STAT3,Signal transducer and activator of transcription 3,HGNC:11364,Src-STAT3 activation renders the cell unable to undergo to ferroptosis.,"Immunoblotting, RNAi, qPCR, western blot, cell viability",Human,MCF-10A and SUM-159 cells,"STAT3 :-: ACSL4, ACSL4 :+: Ferroptosis",Validated,_NA_,Signal transducer and activator of transcription 3,P40763 (STAT3_HUMAN),28972104,_NA_
NFE2L2,"Nuclear factor, erythroid 2 like 2",HGNC:7782,ARF-mediated ferroptosis was largely abrogated by co-expression of NRF2.,"Gene transfection, cell death quantification","Human, mice","H1299, SaoS2, U2OS cells, nude mice","NFE2L2 :+: SLC7A11, SLC7A11 :-: Ferroptosis",Validated,_NA_,Nuclear factor erythroid 2-related factor 2,Q16236 (NF2L2_HUMAN),28985506,NRF2 in article
PML,Promyelocytic leukemia,HGNC:9113,PML expression turned cells highly resistant to ferroptosis.,Cell death assessment,Human,IMR90 cells,PML :-: Ferroptosis,Validated,_NA_,Protein PML,P29590 (PML_HUMAN),29081404,_NA_
MTOR,Mechanistic target of rapamycin kinase,HGNC:3942,"Necessary and sufficient to protect cardiomyocyte cells against ferroptotic cell death. mTOR overexpression suppressed ferroptotic cell death, whereas mTOR deletion exaggerated cell death.","Cell viability assay, ROS production assay, western blot",Mice,"Cardiomyocyte cell, C57BL/6 mice",MTOR :-: Ferroptosis,Validated,_NA_,Serine/threonine-protein kinase mTOR,P42345 (MTOR_HUMAN),29127238,_NA_
NFS1,NFS1 cysteine desulfurase,HGNC:15910,Suppression of NFS1 cooperates with inhibition of cysteine transport to trigger ferroptosis in vitro and slow tumour growth. Suppression of NFS1 predisposes cancer cells to ferroptosis.,"RNAi, cell viability assay,flow cytometry",Human,"MDA-MB-231 cells, NOD.CB17 Scid/J mice","NFS1 :-: TFRC, TFRC :+: Ferroptosis",Validated,_NA_,Cysteine desulfurase,Q9Y697 (NFS1_HUMAN),29168506,_NA_
TP63,Tumor protein p63,HGNC:15979,Delta Np63 alpha can inhibit ferroptosis independent of p53. Overexpression protects cells from ferroptosis-inducing agents.,"siRNA, cell death quantification",Human,ME-180 cells,TP63 :-: Ferroptosis,Validated,_NA_,Tumor protein 63,Q9H3D4 (P63_HUMAN),29212036,Delta Np63 alpha in article
SLC7A11,Solute carrier family 7 member 11,HGNC:11059,Overexperession of SLC7A11 attenuated BAY-inhibited cell viability by ferroptosis.,"Cell viability assay, qRT-PCR, shRNA, gene overexpression, western blot",Human,"MDA-MB-231,  MDA-MB-468, DBTRG-05MG",SLC7A11 :-: Ferroptosis,Validated,_NA_,Cystine/glutamate transporter,Q9UPY5 (XCT_HUMAN),29274359,_NA_
TP53,Tumor protein p53,HGNC:11998,p53 stabilization suppresses ferroptosis. p53 suppresses metabolic stress-induced ferroptosis.,"Immunoblotting, cell death quantification, time-lapse imaging",Human,HT-1080 cells,"TP53 :+: CDKN1A, CDKN1A :+: GSH, GSH :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,Found to promote ferroptosis by other studies.,Cellular tumor antigen p53,P04637 (P53_HUMAN),29346757,p53 in article
CDKN1A,Cyclin dependent kinase inhibitor 1A,HGNC:1784,Required to to suppress ferroptosis.,"CRISPR, shRNA, immunoblotting, cell-cycle profile, cell death quantification",Human,HT-1080 cells,"CDKN1A :+: GSH, GSH :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Cyclin-dependent kinase inhibitor 1,P38936 (CDN1A_HUMAN),29346757,Encoding p21
MIR137,microRNA 137,HGNC:31523,Suppresses ferroptosis both in vitro and in vivo.,"Immunoblotting, luciferase reporter assay, qRT-PCR, cell viability assay, colony formation assay, malondialdehyde assay, iron assay, flow cytometer, shRNA, xenograph mouse model","Human, mice","Melanoma cell lines A375 and G-361, C57BL/6 mice","MIR137 :-: SLC1A5, SLC1A5 :+: Glutaminolysis, Glutaminolysis :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,_NA_,_NA_,29348676,_NA_
SLC40A1,Solute carrier family 40 member 1,HGNC:10909,Overexpression of Fpn inhibited ferroptosis.,"Cell viability assay, lipid ROS measurement, RT-qPCR, western blot",Mice,TM4 Sertoli cells,"SLC40A1 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Solute carrier family 40 member 1,Q9NP59 (S40A1_HUMAN),29436589,Fpn in article
GPX4,Glutathione peroxidase 4,HGNC:4556,Activation blocked ferroptosis.,"Cell viability assay, lipid ROS measurement, RT-qPCR, western blot",Mice,TM4 Sertoli cells,"GPX4 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Phospholipid hydroperoxide glutathione peroxidase,P36969 (GPX4_HUMAN),29436589,_NA_
GPX4,Glutathione peroxidase 4,HGNC:4556,"GPX4-overexpressing cells were resistant to reactive oxygen species-induced cell death. Conversely, GPX4-knockdown cells were sensitive to reactive oxygen species-induced cell death.","Immunohistochemistry, qRT-PCR,lentiviral transduction, shRNA, flow cytometry, cell viability assay",Human,LCL-K cell,"GPX4 :-: 8-OHdG, 8-OHdG :+: Ferroptosis",Deduced,The authors did not determine wether the ROS-induced cell death is related to ferroptosis or not.,Phospholipid hydroperoxide glutathione peroxidase,P36969 (GPX4_HUMAN),29463878,_NA_
ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase 2,HGNC:3357,Overexpression modestly promotes migration and proliferation and significantly inhibits erastin-induced ferroptosis.,"Cell viability assay, qRT-PCR, western blot, ROS measurement, ELISA",Rat,H9c2 cells,ENPP2 :-: Ferroptosis,Validated,_NA_,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Q13822 (ENPP2_HUMAN),29551679,_NA_
VDAC2,Voltage dependent anion channel 2,HGNC:12672,Overexpression could partially protect cells from ferroptosis.,"Western blot, cell viability assay",Human,HT1080 cells,VDAC2 :-: Ferroptosis,Validated,_NA_,Voltage-dependent anion-selective channel protein 2,P45880 (VDAC2_HUMAN),29569437,_NA_
FH,Fumarate hydratase,HGNC:3700,FH inactivation (FH-/- ) proves synthetic lethal with inducers of ferroptosis. FH-/- sensitizes cells to multiple ferroptosis inducers.,"CRISPR/Cas9, sgRNA, cell viability assay, immunoblotting, qPCR, ",Human,"UOK262, HT1080, HK2, A498 cells","FH :+: GPX4, GPX4 :-: Ferroptosis",Validated,_NA_,Fumarate hydratase,P07954 (FUMH_HUMAN),29917289,_NA_
CISD2,CDGSH iron sulfur domain 2,HGNC:24212,Overexpression conferred resistance to ferroptosis. Inhibition blocked resistance to ferroptotic cell death.,"Cell viability and death assay, GSH and ROS levels and lipid peroxidation assays, RNAi, gene transfection, immunoblotting",Human,Head and neck cancer cells,"CISD2 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,CDGSH iron-sulfur domain-containing protein 2,Q8N5K1 (CISD2_HUMAN),29928961,_NA_
SLC40A1,Solute carrier family 40 member 1,HGNC:10909,A negative regulator of ferroptosis by reducing intracellular iron concentration. Knockdown accelerates erastin-induced ferroptosis.,"Cell viability, qRT-PCR, western blot, siRNA",Human,SH-SY5Y cells,"SLC40A1 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Solute carrier family 40 member 1,Q9NP59 (S40A1_HUMAN),29949159,Ferroportin in article
MIR9-1,microRNA 9-1,HGNC:31641,"Overexpression of miR‐9 suppressed GOT1, which subsequently reduced ferroptosis. Suppression of miR‐9 increased the sensitivity of melanoma cells to ferroptosis inducers.","Immunoblotting, luciferase reporter assay, qPCR, cell viability assay, MDA assay, iron assay, glutamate assay",Human,A375 and G‐361 cells,"MIR9 :-: GOT1, GOT1 :+: alpha KG, alpha KG :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,_NA_,_NA_,30035324,miR-9 in article
MIR9-2,microRNA 9-2,HGNC:31642,"Overexpression of miR‐9 suppressed GOT1, which subsequently reduced ferroptosis. Suppression of miR‐9 increased the sensitivity of melanoma cells to ferroptosis inducers.","Immunoblotting, luciferase reporter assay, qPCR, cell viability assay, MDA assay, iron assay, glutamate assay",Human,A375 and G‐361 cells,"MIR9 :-: GOT1, GOT1 :+: alpha KG, alpha KG :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,_NA_,_NA_,30035324,miR-9 in article
MIR9-3,microRNA 9-3,HGNC:31646,"Overexpression of miR‐9 suppressed GOT1, which subsequently reduced ferroptosis. Suppression of miR‐9 increased the sensitivity of melanoma cells to ferroptosis inducers.","Immunoblotting, luciferase reporter assay, qPCR, cell viability assay, MDA assay, iron assay, glutamate assay",Human,A375 and G‐361 cells,"MIR9 :-: GOT1, GOT1 :+: alpha KG, alpha KG :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,_NA_,_NA_,30035324,miR-9 in article
CBS,Cystathionine beta-synthase,HGNC:1550,Inhibition triggers ferroptosis in hepatocellular carcinoma.,"Cell viability, western blotting, LC/ESI-MS/MS, flow cytometry, xenograft mice","Human, mice","HepG2 cells, female ICR mice",CBS :-: Ferroptosis,Validated,_NA_,Cystathionine beta-synthase,P35520 (CBS_HUMAN),30258181,_NA_
NFE2L2,"Nuclear factor, erythroid 2 like 2",HGNC:7782,Associated with resistance to ferroptosis. Inhibition of Nrf2 sensitized cells to ferroptosis.,"Cell viability and cell death assays, ROS production measurement, RNAi, gene transfection, immunoblotting","Human, mice","HNC cell line (AMC-HN2–11), SNUcell lines (SNU-1041, -1066, and -1076), athymic BALB/c male nude mice","NFE2L2 :+: FTH1, FTH1 :-: Ferroptosis, NFE2L2 :+: FPN, FPN :-: Ferroptosis, NFE2L2 :+: HO-1, HO-1 :-: Ferroptosis",Validated,_NA_,Nuclear factor erythroid 2-related factor 2,Q16236 (NF2L2_HUMAN),30339884,Nrf2 in article
SQSTM1,Sequestosome 1,HGNC:11280,"Inhibition of the p62 gene significantly reduced cell viability and increased cellular lipid ROS levels in HN3R cells; this was reversed by treatment with ferrostatin-1, a ferroptosis inducer.","siRNA, qPRC, fluorescent microscopy and flow cytometry, ROS production measurement",Human,HN3 cells,"SQSTM1 :+: NFE2L2, NFE2L2 :+: FTH1, FTH1 :-: Ferroptosis, NFE2L2 :+: FPN, FPN :-: Ferroptosis, NFE2L2 :+: HO-1, HO-1 :-: Ferroptosis",Validated,Not test cell death or cell viability.,Sequestosome-1,Q13501 (SQSTM_HUMAN),30339884,p62 in article.
GPX4,Glutathione peroxidase 4,HGNC:4556,"Overexpression GPX4 resulted in decreased cell death after RSL3 treatment. Moreover, this effect was able to be reversed by overexpression of GPX4.","Cell viability, cell death, ROS determination, western blot",Human,"HCT116, LoVo, and HT29 CRC cells",GPX4 :-: Ferroptosis,Validated,_NA_,Phospholipid hydroperoxide glutathione peroxidase,P36969 (GPX4_HUMAN),30524291,_NA_
ISCU,Iron-sulfur cluster assembly enzyme,HGNC:29882,Over expression significantly attenuated DHA induced ferroptosis.,"Cell viability, cell cycle, ROS determination, western blot, immunofluorescence, ectopic expressing, lentiviral transduction",Human,"HL60, KG1, THP-1 cells","ISCU :+: GSH, GSH :-: Ferroptosis",Validated,_NA_,Iron-sulfur cluster assembly enzyme ISCU,Q9H1K1 (ISCU_HUMAN),30557609,_NA_
FTH1,Ferritin heavy chain 1,HGNC:3976,FTH reconstituted cells exhibited the reduced lipid peroxides content and restored the DHA-induced ferroptosis.,"Cell viability, cell cycle, ROS determination, western blot, immunofluorescence, ectopic expressing, lentiviral transduction",Human,"HL60, KG1, THP-1 cells","FTH1 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Ferritin heavy chain,P02794 (FRIH_HUMAN),30557609,FTH in article
ACSL3,Acyl-CoA synthetase long chain family member 3,HGNC:3570,Required for exogenous monounsaturated fatty acids to protect cells against ferroptosis. Negatively correlates with ferroptosis sensitivity.,"Dead cell count, gene knockout, confocal imaging, thin-layer chromatography, BODIPY 493/503 imaging, CRISPR/Cas9, RT-qPCR, western blot",Human,"HEK293, HT-1080 cells",ACSL3 :-: Ferroptosis,Validated,_NA_,Long-chain-fatty-acid--CoA ligase 3,O95573 (ACSL3_HUMAN),30686757,_NA_
OTUB1,"OTU deubiquitinase, ubiquitin aldehyde binding 1",HGNC:23077,Inactivation promotes ferroptosis by down-regulating SLC7A11 levels. Overexpression is critical for tumor growth.,"CRISPR/Cas9, RNAi, cell death, western blot, qRT-PCR","Human, mice","H1299, SK-N-BE(2)C, T24, UM-UC-3, SW780 cells, nude mice","OTUB1 :+: SLC7A11, SLC7A11 :-: Ferroptosis",Validated,_NA_,Ubiquitin thioesterase OTUB1,Q96FW1 (OTUB1_HUMAN),30709928,_NA_
CD44,CD44 molecule (Indian blood group),HGNC:1681,Knockdown sensitizes cells to ferroptosis.,"Western blot, siRNA, cell death",Human,H1299 cells,"CD44 :+: SLC7A11, SLC7A11 :-: Ferroptosis",Validated,_NA_,CD44 antigen,P16070 (CD44_HUMAN),30709928,_NA_
LINC00336,Long intergenic non-protein coding RNA 336,HGNC:33813,Overexpression inhibits ferroptosis. Knockdown promotes ferroptosis.,"qRT-PCR, MTT assay, colony-formation assay, lipid ROS assays, iron assay, immunoblotting",Human,A549 and SPC-A-1 cells,(LINC00336/ELAVL1) :-: Ferroptosis,Validated,_NA_,Putative uncharacterized protein encoded by LINC00336,Q6ZUF6 (NC336_HUMAN),30787392,_NA_
STAT3,Signal transducer and activator of transcription 3,HGNC:11364,Upregulated in ferroptosis resistant cells. Inhibition increases ferroptosis.,"Cell viability tests, ROS and lipid peroxidation measures, MDA measurement, western blot",Human,Osteosarcoma cells MG63 and Saos-2,STAT3 :-: Ferroptosis,Validated,_NA_,Signal transducer and activator of transcription 3,P40763 (STAT3_HUMAN),30811078,_NA_
BRD4,Bromodomain containing 4,HGNC:13575,Inhibition induces ferroptosis.,"Cell proliferation assay, migration and invasion assays, RT-PCR, western blot, immunohistochemistry, iron assay",Human,"MDA-MB-231, Hs578T, H1299, A549 and MCF-10A cells, female athymic BALB/c nude mice","BRD4 :-: Ferritinophagy, Ferritinophagy :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Bromodomain-containing protein 4,O60885 (BRD4_HUMAN),30988278,_NA_
PRDX6,Peroxiredoxin 6,HGNC:16753,A negative regulator of ferroptotic cell death.,"Western blot, flow cytometry, SRB assay, gene transfection, shRNA, LOOH quantification",Human,H1299 cells,"PRDX6 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Peroxiredoxin-6,P30041 (PRDX6_HUMAN),31036877,_NA_
MIR17,microRNA 17,HGNC:31547,Protects endothelial HUVEC cells from erastin-induced ferroptosis. Overexpression significantly reduced erastin-induced growth inhibition and ROS generation of HUVEC cells.,"Lentivirus transduction, CCK-8 assay, DYE670 staining assay, ROS staining assay, RT-qPCR, western blot",Human,HUVEC cells,"MIR17 :-: A20, A20 :+: ACSL4, ACSL4 :+: Lipid ROS, A20 :-: GPX4, GPX4 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,_NA_,_NA_,31160087,miR-17-92 in article
SCD,Stearoyl-CoA desaturase,HGNC:10571,Inhibition of SCD1 induces ferroptotic cell death. Expression of SCD1 protects cells from ferroptosis.,"Cell viability, cell death, BODIPY staining, siRNA, RT-qPCR, western blot, gene overexpression, ","Human, mice","OVCAR-4, COV362, FT-t cells, mouse orthotopic xenograft model","SCD :+: CoQ10, CoQ10 :-: Ferroptosis",Validated,_NA_,Acyl-CoA desaturase,O00767 (ACOD_HUMAN),31270077,SCD1 in article
SESN2,Sestrin 2,HGNC:20746,"Has cytoprotective effect against ferroptosis. In cells expressing Sesn2, erastin-induced cell death, ROS formation, and glutathione depletion were almost completely inhibited compared to that in control cells.","MTT assay, RT-PCR, luciferase assay, immunoblot, siRNA, Lipid peroxidation assay, GSH measurement","Human, mice","HepG2 and AML-12 cell lines, mouse embryonic fibroblasts cells, ICR mice","SESN2 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Sestrin-2,P58004 (SESN2_HUMAN),31323261,Sesn2 in article
NF2,Neurofibromin 2,HGNC:7773,Genetic inactivation of NF2 rendered cancer cells more sensitive to ferroptosis. Mediates cell density-dependent inhibition of ferroptosis.,"Cell death, cell viability, lipid peroxidation, immunoblotting, CRISPR/Cas9, ChIP assay, qRT-PCR","Human, mice","Mouse embryonic fibroblasts, NF639 cells, human epithelial tumour cells, human mesothelioma cells, xenograft mouse","NF2 :-: YAP, YAP :+: Ferroptosis",Validated,_NA_,Merlin,P35240 (MERL_HUMAN),31341276,Also known as merlin
ARNTL,Aryl hydrocarbon receptor nuclear translocator like,HGNC:701,Degration of the protein is critical for ferroptosis. Blocking ARNTL degradation diminished ferroptotic tumor cell death.,"Cytotoxicity assays, western blot, immunoprecipitation, RNA interference, gene transfection, qPCR, MDA assay","Human, mice","Calu-1, THP1, HT1080, and HL-60 cells, athymic nude mice","ARNTL :-: EGLN2, EGLN2 :-: HIF1A, HIF1A  :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Aryl hydrocarbon receptor nuclear translocator-like protein 1,O00327 (BMAL1_HUMAN),31355331,_NA_
HIF1A,Hypoxia inducible factor 1 subunit alpha,HGNC:4910,Destabilizing HIF1A facilitated ferroptotic tumor cell death.,"Cytotoxicity assays, western blot, immunoprecipitation, RNA interference, gene transfection, qPCR, MDA assay","Human, mice","Calu-1, THP1, HT1080, and HL-60 cells, athymic nude mice","HIF1A  :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Hypoxia-inducible factor 1-alpha,Q16665 (HIF1A_HUMAN),31355331,_NA_
JUN,"Jun proto-oncogene, AP-1 transcription factor subunit",HGNC:6204,O-GlcNAcylated c-Jun represents an obstructive factor to ferroptosis.,"Immunofluorescence, western blotting, immunohistochemistry, cell viability, colony formation, qPCR, lipid peroxidation assay, iron assay","Human, mice","Bel-7402, SMMC-7721 cells, athymic nude mice","JUN :+: GSH, GSH :-: Ferroptosis, JUN :+: PSAT1, PSAT1 :-: Ferroptosis, JUN :+: CBS, CBS :-: Ferroptosis",Deduced,_NA_,Transcription factor AP-1,P05412 (JUN_HUMAN),31394193,c-Jun in article
CA9,Carbonic anhydrase 9,HGNC:1383,Inhibition induces ferroptosis.,"qRT-PCR, western blot, cell viability assay, siRNA, ROS detection",Human,"Mesothelioma cell lines ACC-Meso-1, NCI-H2373 and NCI-H2052, mesothelial cell line MeT-5A",CA9 :-: Ferroptosis,Validated,_NA_,Carbonic anhydrase 9,Q16790 (CAH9_HUMAN),31442913,_NA_
HSPA5,Heat shock protein family A (Hsp70) member 5,HGNC:5238,Knockdown of GRP78 enhanced artesunate-induced ferroptosis of pancreatic cancer cells.,"Fluorescent staining, CCK8, Western blot, shRNA, qRT-PCR","Human, mice","Pancreatic cancer cells AsPC-1 and PaTU8988, BALB/c nude mice","GRP78 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Endoplasmic reticulum chaperone BiP,P11021 (BIP_HUMAN),31456633,GRP78 in article
TMBIM4,Transmembrane BAX inhibitor motif containing 4,HGNC:24257,Protects against ferroptosis in HCC cells. Inhibition increased ferroptotic cel death.,"Cell viability and clonogenic survival assay, immunofluorescence, western blot, RNAi, gene transfection, qRT-PCR, lipid peroxidation assay","Human, mice","Hep G2, Huh‐7, SMMC‐7721 and PLC/PRF/5 cells, nude mice",S1R :-: Ferroptosis,Validated,_NA_,Protein lifeguard 4,Q9HC24 (LFG4_HUMAN),31507082,S1R in article
HSPA5,Heat shock protein family A (Hsp70) member 5,HGNC:5238,Serves as a negative regulator of DHA-induced ferroptosis.,"Cell viability, colony formation, cell death, lipid ROS assay, GSH determination, siRNA, western blot, RT-PCR, xenograft tumor model","Human, mice","Glioma cell lines U251 and U373, mouse hippocampal neuronal cell line HT22, athymic nude BALB/c mice","HSPA5 :+: GPX4, GPX4 :-: Ferroptosis",Predicted,_NA_,Endoplasmic reticulum chaperone BiP,P11021 (BIP_HUMAN),31519193,_NA_
PLIN2,Perilipin 2,HGNC:248,An indispensable gene and protein in the suppression of ferroptosis caused by abnormal lipometabolism in gastric carcinoma.,"Cell proliferation and clonogenic assay, cell survival analysis, xenografts tumor, RNA-seq, RT‑qPCR, ROS assay","Human, mice","SGC7901 and MGC803 cells, nude mice",PLIN2 :-: Ferroptosis,Screened,_NA_,Perilipin-2,Q99541 (PLIN2_HUMAN),31520166,Also known as ADRP
MIR212,microRNA 212,HGNC:31589,Overexpression of miR-212-5p attenuated ferroptosis while downregulation of miR-212-5p promoted ferroptotic cell death.,"Controlled cortical impact model, iron assay, MDA assay, RT-PCR, western blotting, cell death",Mice,"HT22 and Neuro-2a cells, C57BL/6 J mice",(miR-212-5p/Ptgs2) :-: Ferroptosis,Validated,_NA_,_NA_,_NA_,31533781,miR-212-5p in article
Fer1HCH,Ferritin 1 Heavy Chain Homolog,_NA_,Reduced heavy chain levels caused severe mitochondrial defects and ferroptosis.,"RT-qPCR, immunohistochemistry, EdU staining, TUNEL staining",Drosophila,Fly,"Fer1HCH :-: ROS, ROS :+: Ferroptosis",Predicted,_NA_,Ferritin,H1UUD2 (H1UUD2_DROME),31568497,_NA_
AIFM2,Apoptosis inducing factor mitochondria associated 2,HGNC:21411,A glutathione-independent ferroptosis suppressor. Pharmacological targeting of FSP1 strongly synergizes with GPX4 inhibitors to trigger ferroptosis.,"Expression cloning, cell death, cell viability, LDH assay, western blot, LC-MS, NADH consumption assay","Human, mice","MCF-7, HT1080, Pfa1 cells","FPS1 :+: CoQ10, CoQ10 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Apoptosis-inducing factor 2,Q9BRQ8 (AIFM2_HUMAN),31634899,FSP1 in article
AIFM2,Apoptosis inducing factor mitochondria associated 2,HGNC:21411,A potent ferroptosis-resistance factor. Positively correlates with ferroptosis resistance.,"Synthetic lethal CRISPR-Cas9 screen, cell death, western blotting, lipid droplet fractionation, glutathione measurement, tumour xenograft growth, CoQ measurement","Human, mice","U-2 OS cell line, NCI-H460, NCI-H2291, NCI-H1703 and NCIH446 cells, C.B17 SCID mice","FPS1 :+: CoQ10, CoQ10 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Apoptosis-inducing factor 2,Q9BRQ8 (AIFM2_HUMAN),31634900,FSP1 in article
LAMP2,Lysosomal associated membrane protein 2,HGNC:6501,Knockdown promoted ferroptosis.,"Cell viability, western blot, ROS induction, glutathione assay, lipid peroxidation assay",Human,"ARPE-19, hfRPE cells","LAMP2 :+: Cysteine, Cysteine :+: GSH, GSH :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Lysosome-associated membrane glycoprotein 2,P13473 (LAMP2_HUMAN),31672277,_NA_
ZFP36,ZFP36 ring finger protein,HGNC:12862,ZFP36 plasmid impaired FBXW7 plasmid-induced HSC ferroptosis. Overexpression of Zfp36 impaired erastin- or sorafenib-induced ferroptosis.,"Cell viability, lipid peroxidation, iron, GSH and ROS assays, western blot, RT-PCR, RNA-seq","Human, mice","Hepatic stellate cells, C57BL/6 mice","ZFP36 :-: ATG16L1, ATG16L1 :+: Ferroptosis",Validated,_NA_,mRNA decay activator protein ZFP36,P26651 (TTP_HUMAN),31679460,_NA_
GPX4,Glutathione peroxidase 4,HGNC:4556,Depletion or inhibition resulted in cell death by ferroptosis.,"Quantitative proteomic analysis, siRNA, RNA-seq and qRT-PCR, cell viability, lipid peroxidation assay, GSH measurement, western blot","Human, mice, rat","H9c2 and C2C12 cells, rat ventricular myocytes, C57BL/6 mice","GPX4 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Phospholipid hydroperoxide glutathione peroxidase,P36969 (GPX4_HUMAN),31685805,_NA_
PROM2,Prominin 2,HGNC:20685,Induced by ferroptotic stress and promotes resistance to ferroptotic cell death. Facilitates ferroptosis resistance in mammary epithelial and breast carcinoma cells.,"RNA-seq, western blot, qPCR, siRNA, cell count, cell death, iron assay",Human,"MCF10A, Hs578t and MDA-MB-231 cells","Prominin2 :+: Ferritin-containing MVB, Ferritin-containing MVB :-: Ferroptosis",Validated,_NA_,Prominin-2,Q8N271 (PROM2_HUMAN),31735663,Prominin2 in article
CHMP5,Charged multivesicular body protein 5,HGNC:26942,"Ferroptosis activators increase ESCRT-III subunits (e.g., CHMP5 and CHMP6). Knockdown of CHMP5 or CHMP6 sensitizes human cancer cells to ferroptosis.","RNAi, western blot, iron, malondialdehyde and cytotoxicity assays","Human, mice","PANC1 and HepG2 cells, athymic nude or B6 mice",CHMP5 :-: Ferroptosis,Validated,_NA_,Charged multivesicular body protein 5,Q9NZZ3 (CHMP5_HUMAN),31761326,_NA_
CHMP6,Charged multivesicular body protein 6,HGNC:25675,"Ferroptosis activators increase ESCRT-III subunits (e.g., CHMP5 and CHMP6). Knockdown of CHMP5 or CHMP6 sensitizes human cancer cells to ferroptosis.","RNAi, western blot, iron, malondialdehyde and cytotoxicity assays","Human, mice","PANC1 and HepG2 cells, athymic nude or B6 mice",CHMP6 :-: Ferroptosis,Validated,_NA_,Charged multivesicular body protein 6,Q96FZ7 (CHMP6_HUMAN),31761326,_NA_
AKR1C1,Aldo-keto reductase family 1 member C1,HGNC:384,Inhibition completely resensitizes resistant melanoma cells to ferroptosis execution.,"RNAi, cell transfection, western blotting, qRT-PCR, cell viability, lipid peroxides evaluation",Human,"MeWo, A2058, SK-Mel 5, SK-Mel 24, C8161, CHL-1, and A375 cells","AKR1C1 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Aldo-keto reductase family 1 member C1,Q04828 (AK1C1_HUMAN),31780644,_NA_
AKR1C2,Aldo-keto reductase family 1 member C2,HGNC:385,Inhibition completely resensitizes resistant melanoma cells to ferroptosis execution.,"RNAi, cell transfection, western blotting, qRT-PCR, cell viability, lipid peroxides evaluation",Human,"MeWo, A2058, SK-Mel 5, SK-Mel 24, C8161, CHL-1, and A375 cells","AKR1C2 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Aldo-keto reductase family 1 member C2,P52895 (AK1C2_HUMAN),31780644,_NA_
AKR1C3,Aldo-keto reductase family 1 member C3,HGNC:386,Inhibition completely resensitizes resistant melanoma cells to ferroptosis execution.,"RNAi, cell transfection, western blotting, qRT-PCR, cell viability, lipid peroxides evaluation",Human,"MeWo, A2058, SK-Mel 5, SK-Mel 24, C8161, CHL-1, and A375 cells","AKR1C3 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Aldo-keto reductase family 1 member C3,P42330 (AK1C3_HUMAN),31780644,_NA_
CBS,Cystathionine beta-synthase,HGNC:1550,"Knockdown in erastin-resistant cells caused ferroptotic cell death, while overexpression conferred ferroptosis resistance.","RNAi, cell viability, ROS analysis, GSH, glutamate release and cystine uptake assays, western blotting, qRT-PCR",Human,SKOV3 and OVCA429 cells,"CBS :+: Cystathionine, Cystathionine :+: Cysteine, Cysteine :+: GSH, GSH :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Cystathionine beta-synthase,P35520 (CBS_HUMAN),31819185,_NA_
NFE2L2,"Nuclear factor, erythroid 2 like 2",HGNC:7782,Genetically repression of NRF2 enhanced ferroptosis susceptibility.,"RNAi, cell viability, ROS analysis, GSH, glutamate release and cystine uptake assays, western blotting, qRT-PCR",Human,SKOV3 and OVCA429 cells,"NFE2L2 :+: CBS :+: Cystathionine, Cystathionine :+: Cysteine, Cysteine :+: GSH, GSH :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Nuclear factor erythroid 2-related factor 2,Q16236 (NF2L2_HUMAN),31819185,NRF2 in article
CAV1,Caveolin 1,HGNC:1527,"Cav-1 deficiency aggravated ferroptosis. Short hairpin RNA of Cav-1 promoted ferroptosis, which was ameliorated by Cav-1 overexpression. ","Immunofluorescence, western blot, ROS detection","Human, mice","LO2 cells, mice model","CAV-1 :+: xCT, xCT :+: GPX4, GPX4 :-: Ferroptosis, CAV-1 :-: RNS, RNS :+: Ferroptosis",Validated,_NA_,Caveolin-1,Q03135 (CAV1_HUMAN),31877357,Cav-1 in article
GCH1,GTP cyclohydrolase 1,HGNC:4193,Gch1 overexpression and its downstream metabolites BH4/BH2 rescue from ferroptosis. Inhibition of GCH1 activity can sensitize resistant cancer cells to ferroptosis induction.,"CRISPR activation screening, qRT-PCR, cell viability, cell counts, western blot",Human,"HT-1080,786-O, A-498, Caki-1, AU565, DU4475, MCF-7 cells","GCH1 :+: Phospholipid, Phospholipid :-: Ferroptosis, GCH1 :+: COQ10, COQ10 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,GTP cyclohydrolase 1,P30793 (GCH1_HUMAN),31989025,_NA_